tiprankstipranks

Eiry Roberts Insider Profile

4 Followers
Eiry Roberts, CMO at Neurocrine, holds 23.72K shares in Neurocrine (Ticker: NBIX), holds 44.01K shares in Amicus (Ticker: FOLD).
tipranks
Eiry Roberts

Eiry Roberts
Neurocrine (NBIX)
CMO

Not Ranked
Eiry Roberts has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
88.89%
11.11%
A breakdown of Eiry Roberts's holdings

Insider Roles

Neurocrine
(NBIX)
CMO
Amicus
(FOLD)
Director
Roles that Eiry Roberts holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Eiry Roberts

Eiry Roberts's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Neurocrine
Feb 15, 2024
CMO
Uninformative Sell
148.12K
$3.28M
Amicus
Jun 12, 2023
Director
Uninformative Buy
$410.65K
List of latest transactions for each holding click on a transaction to see Eiry Roberts's performance on stock

Eiry Roberts insider profile FAQ

What is the percentage of profitable transactions made by Eiry Roberts?
The percentage of profitable transactions made by Eiry Roberts is ―.
    What is the average return per transaction made by Eiry Roberts?
    The average return per transaction made by Eiry Roberts is ―.
      What stocks does Eiry Roberts hold?
      Eiry Roberts holds: NBIX, FOLD stocks.
        What was Eiry Roberts’s latest transaction?
        Eiry Roberts latest transaction was an Uninformative Sell of $148.12K.
          What was Eiry Roberts's most profitable transaction?
          Eiry Roberts’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Eiry Roberts's role in Neurocrine?
            Eiry Roberts's role in Neurocrine is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.